Arquivamento definitivo - Art. 33 da LPI
#11.1.1
03/21/2023
RPI 2724
Application data
Number
112021005539Type
Filing
Publication
PCT
US2019052952 The application was abandoned: examination was not requested within the 36 months following the 09/25/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 03/21/2023. We update with every new RPI gazette, published weekly.
Applicants
CELATOR PHARMACEUTICALS, INC.
US
Inventors
Q. W. (pessoa física)
US
R. C. (pessoa física)
US
S. F. (pessoa física)
US
IPC Classification
Priority claims
US
62/736,393 · 09/25/2018
US
62/772,372 · 11/28/2018
Abstract
TRATAMENTO DE BAIXA INTENSIDADE DETRANSTORNOS HEMATOLÓGICOS.A presente invenção refere-se a composições e métodos para tratar pacientes com transtornos proliferativos hematológicos que são inelegíveis para tratamento com quimioterapia intensiva padrão usando tratamento de baixa intensidade com CPX-351, uma composição lipossômica de daunorrubicina e citarabina.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
03/21/2023
RPI 2724
#11.1
01/03/2023
RPI 2713
#1.3
06/29/2021
RPI 2634
#1.1
04/06/2021
RPI 2622
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.